The femoral-facial syndrome is a very rare syndrome of uncertain inheritance comprising hypoplastic femora, microretrognathia, and a peculiar facies. We report an additional observation detected by ultrasound at 25 weeks and diagnosed at birth. In addition to the malformations usually described in this syndrome, there were heterotopias of the brain, partial agenesis of the corpus caliosum, bilobed lungs, intestinal malrotation, and vertebral segmentation defects.
First described by Daentl et al' in 1975, the femoral-facial syndrome, or FFS,2 was initially called femoral hypoplasia-unusual facies syndrome. When the full syndrome is observed, it comprises Pierre-Robin sequence, facial dysmorphism, and femoral hypoplasia. Subsequently 19 observations have been published and most are female. However, there is clinical heterogeneity. In this report we present a severe and lethal type with some unreported findings. were downward slanting, the mouth was small and downturned, and complete Pierre-Robin sequence was observed with cleft palate, microretrognathia, and glossoptosis (fig 2) . The ' 4 Regarding our observation, the hypothesis of fetal constraint is unlikely, amniotic fluid being abundant on serial ultrasound examination. However, the CNS abnormalities and the camptodactyly would be compatible with the so-called fetal hypokinesia sequence. Maternal diabetes has been recognised as a causative agent in more than 20% of the reported cases of FFS. Of note is the sacral hemivertebra that can occur in the classical caudal regression sequence, which can be observed in infants born to diabetic mothers and was present in our case. However, diabetes was excluded by OGTT during pregnancy. Ketotifenum, like other broncholytic drugs, is often used during pregnancy and has not previously been recognised as a teratogenic agent.
A similar set of malformations can be observed in other multiple malformation syndromes. Campomelic syndrome has a somewhat different skeletal dysplasia and facial dysmorphism and is invariably associated with dwarfism. Smith-Lemli-Opitz syndrome type II is associated with Pierre-Robin sequence, polydactyly, lung segmentation defects, and hypotonia,5 but the facial dysmorphism is quite different and syndactyly of the second and third toes is nearly constant. The Char syndrome6 also shows some similarities, as does VerlooveVanhoorick syndrome.7 However, some specific malformations of the latter (rhizomelia of the lower and upper limbs, cardiac and renal defects, absent auditory canal, oligodactyly) were absent in our patient. Finally, we have no indication (family history, clinical examination ofthe parents) of a specific mode of inheritance. However, with respect to similarities to conditions like campomelic dysplasia, which have been recently shown to occur as a consequence of dominant neomutational events, this mode of inheritance is an attractive hypothesis.
In conclusion, our observation confirms, together with those of Robinow et af and Tadmor et al,8 the feasibility ofprenatal diagnosis of this condition, based on ultrasound visualisation of shortened, bowed femora in association with microretrognathia. This can theoretically be achieved as early as the 18th week of gestation. In addition, we suggest that CNS abnormalities, including neuronal migration defects, enlargement of the lateral ventricles, and partial agenesis of the corpus callosum, as well as vertebral segmentation defects are additional components of the syndrome.
